Spatially Resolving the Secretome within the Mycelium of the Cell Factory <i>Aspergillus niger</i> حسب Pauline Krijgsheld (1973917)

Spatially Resolving the Secretome within the Mycelium of the Cell Factory <i>Aspergillus niger</i> حسب Pauline Krijgsheld (1973917)

Spatially Resolving the Secretome within the Mycelium of the Cell Factory <i>Aspergillus niger</i> حسب Pauline Krijgsheld (1973917)

Data Sheet 2_The Learn Together programme (part A): co-designing an approach to support patient and family involvement and engagement in patient safety incident investigations.pdf حسب Jane K. O’Hara (8828342)

الموضوعات:

Data Sheet 3_The Learn Together programme (part A): co-designing an approach to support patient and family involvement and engagement in patient safety incident investigations.pdf حسب Jane K. O’Hara (8828342)

الموضوعات:

Data Sheet 1_The Learn Together programme (part A): co-designing an approach to support patient and family involvement and engagement in patient safety incident investigations.pdf حسب Jane K. O’Hara (8828342)

الموضوعات:

Time to self-harm event after admission during most recent incarceration. حسب Hygiea Casiano (2189752)

Demographic correlates of self-harm while in youth custody during most recent incarceration. حسب Hygiea Casiano (2189752)

Examples of terms used in the academic literature to describe practice encounters not involving in-person contact. حسب Kathleen Leslie (15374710)

Reasons and patterns of self-harm patients. حسب Willie Njoroge (20623714)

الموضوعات:

Self-harm patients’ spiritual history. حسب Willie Njoroge (20623714)

الموضوعات:

Compartmentalization as tobacco industry tactic to distract from health harms of cigarettes [57]. حسب Yogi Hale Hendlin (5158895)

Participants’ perceptions of the likelihood of being harmed when receiving hospital or ambulatory care from 2019 to 2023 (N = 1000 per year). حسب Olga Amberger (20299807)

A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity-6 حسب Denise A Gonzales (38545)

"…The RR of CIN would have to be less than 0.67 in order for the RR of hemodialysis not to be on the side of harm (RR < 1).…"

Development of immune factors over visits in the AAF and AAF-syn treatment group as (A) scores and (B) loadings. حسب Diana M. Hendrickx (1507435)

Results of comparing visits within allergy groups using linear mixed models and post hoc analysis. حسب Diana M. Hendrickx (1507435)

Results of comparing allergy groups within visits using linear mixed models and post hoc analysis. حسب Diana M. Hendrickx (1507435)

Development of immune factors over visits in the AAF-syn treatment group as (A) scores and (B) loadings when using the AAF treatment group as a reference. حسب Diana M. Hendrickx (1507435)

Results of comparing treatment groups within visits using linear mixed models and post hoc analysis. حسب Diana M. Hendrickx (1507435)

Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within allergy groups as determined by linear mixed models and post hoc analysis. حسب Diana M. Hendrickx (1507435)